83 related articles for article (PubMed ID: 4060201)
21. Management of nonsinonasal neuroendocrine carcinomas of the head and neck.
Barker JL; Glisson BS; Garden AS; El-Naggar AK; Morrison WH; Ang KK; Chao KS; Clayman G; Rosenthal DI
Cancer; 2003 Dec; 98(11):2322-8. PubMed ID: 14635065
[TBL] [Abstract][Full Text] [Related]
22. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
[TBL] [Abstract][Full Text] [Related]
23. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
[TBL] [Abstract][Full Text] [Related]
24. [Irradiation combined with bleomycin. 5-year results with 27 O.R.L. epitheliomas (proceedings)].
Baillet F
J Radiol Electrol Med Nucl; 1978 Nov; 59(11):634. PubMed ID: 85709
[No Abstract] [Full Text] [Related]
25. [Cervical lymphatic metastases from occult primary tumor. A nation-wide 20-year study from the Danish society of head and neck oncology].
Grau C; Johansen LV; Jakobsen J; Geertsen PF; Andersen EV; Jensen BB
Ugeskr Laeger; 2001 Mar; 163(10):1432-6. PubMed ID: 11257752
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
27. [Experience in the use of face masks for radiotherapy of head and neck tumors].
Niewald M; Lehmann W; Uhlmann U; Berberich W; Scharding B; Dietz R; Schnabel K; Leetz HK
Strahlentherapie; 1985 Nov; 161(11):681-4. PubMed ID: 4071568
[TBL] [Abstract][Full Text] [Related]
28. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
[TBL] [Abstract][Full Text] [Related]
29. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
30. [Changes in aerobic bacterial flora in the oral cavity of subjects with neoplasms of the head and neck area undergoing antiblastic therapy].
Gismondo MR; Romeo MA; Serra A; Arcidiacono A; La Mantia I
G Batteriol Virol Immunol; 1982; 75(7-12):383-9. PubMed ID: 7188268
[TBL] [Abstract][Full Text] [Related]
31. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients.
Rades D; Fehlauer F; Bajrovic A; Mahlmann B; Richter E; Alberti W
Radiother Oncol; 2004 Mar; 70(3):261-4. PubMed ID: 15064010
[TBL] [Abstract][Full Text] [Related]
32. [Effect of combined resorptive preparations containing prospidin and Yttrium-90 on certain strains of tumors].
Dedenkov AN
Med Radiol (Mosk); 1976 Jan; 21(1):36-40. PubMed ID: 933733
[No Abstract] [Full Text] [Related]
33. Results of treatment of inoperable recurrences of laryngeal cancer after total laryngectomy.
Sas-Korczyńska B; Korzeniowski S; Skolyszewski J
Strahlenther Onkol; 1996 Feb; 172(2):99-102. PubMed ID: 8669051
[TBL] [Abstract][Full Text] [Related]
34. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community.
Maguire PD; Meyerson MB; Neal CR; Hamann MS; Bost AL; Anagnost JW; Ungaro PC; Pollock HD; McMurray JE; Wilson EP; Kotwall CA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):698-704. PubMed ID: 14967423
[TBL] [Abstract][Full Text] [Related]
35. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice.
Veness MJ; Morgan GJ; Palme CE; Gebski V
Laryngoscope; 2005 May; 115(5):870-5. PubMed ID: 15867656
[TBL] [Abstract][Full Text] [Related]
36. [Prospidin in combination with gamma teletherapy in treating esophageal cancer].
Kusherbaev SK; Filippenko VI; Turganbaeva DA; Urbisinov ZhK
Med Radiol (Mosk); 1979 May; 24(5):21-6. PubMed ID: 374920
[No Abstract] [Full Text] [Related]
37. Does clinical and radiological response predict complete tumor control in N2-N3 squamous cell head and neck cancer after non-operative management of the neck?
Dequanter D; Lothaire P; Awada A; Lalami Y; Hien Nguyen T; Lemort M; Vandevelde L; Andry G
Acta Otolaryngol; 2006 Dec; 126(11):1225-8. PubMed ID: 17050318
[TBL] [Abstract][Full Text] [Related]
38. [Clinical analysis of small cell neuroendocrine carcinoma of the head and neck].
Li ZJ; Li HZ; Liu WS; Xu ZG; Tang PZ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3275-8. PubMed ID: 19159554
[TBL] [Abstract][Full Text] [Related]
39. Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials.
Rewari AN; Haffty BG; Wilson LD; Son YH; Joe JK; Ross DA; Papac RJ; Sasaki CT; Fischer JJ
Cancer J; 2006; 12(2):123-9. PubMed ID: 16630403
[TBL] [Abstract][Full Text] [Related]
40. Normobaric oxygen as a sensitizer in radiotherapy for advanced head and neck cancer.
Zajusz A; Maciejewski B; Hliniak A
Neoplasma; 1995; 42(3):137-40. PubMed ID: 7637824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
